Taking advantage of mixed messages
Living with AIDS # 229
KHOPOTSO: Tessa Michael is a former social worker from the Charles Hurwitz TB Hospital in Diepkloof, Soweto. These days she runs a private consultancy service in Johannesburg, advising companies on how to handle HIV in the workplace and counselling infected people. She says a big part of her work is to advise clients on what treatment to take to keep healthy and when they fall sick. She recommends a treatment regimen comprising of nutrition and vitamin supplements, minus antiretrovirals.
TESSA MICHAEL: There’s a big gap in terms of identifying your status and then actually going on to ARVs. The government’s policy is currently that you do not go on to ARVs until your CD4 (count) is 200 or below, or unless if you are constantly getting sick. I prefer people to really look after their health the moment they are identified as being HIV positive and move into a health regimen that will support them so that they never need to get to a state where their CD4 (count) has fallen so low that they have to get on to ARVs.
KHOPOTSO: She goes on.
TESSA MICHAEL: I agree with you that if people are identified as being HIV positive and if you have a massive viral load and your CD4 (count) is low that, at that point, it might be necessary to go on to ARVs in combination with good supplements and, obviously, good nutrition. The problem is that remaining on your ARVs over a long period you eventually reach a point where your body cannot tolerate such massive doses of something that is so powerful. It affects things like the liver, the brain, the kidneys.
KHOPOTSO: Michael might well have a point. At the end of the recent World Health Organisation Consultation meeting on Nutrition and HIV/AIDS in Africa, participating countries, including South Africa, adopted a policy statement. It acknowledges that ‘long term use of ARVs can be associated with metabolic complications, such as cardiovascular disease, diabetes and bone related problems’. However, it goes on to say that ‘the value of ARV therapy far outweighs the risks and the metabolic complications need to be adequately managed’. But Michael will not be moved from advising her clients to take only multivitamins as treatment for their HIV and AIDS infection.
TESSA MICHAEL: I would especially recommend an amino-acid called Lysine’¦ I would recommend selenium’¦ And you really should be on a good vitamin. Your B complex vitamins all help your red blood (cells). If your red blood (cells) are in good condition, that means you’re taking enough oxygen to feed the whole body. For your body to be healthy you need sufficient oxygen in the body.
KHOPOTSO: The good role multivitamins play in the management of HIV and AIDS cannot be over-emphasised. But it becomes a great concern when people are told to never go on antiretrovirals, especially when their health status requires that they should start this form of treatment. Collen tested HIV positive in 1997. He looks and feels fit as a fiddle. Yet his CD4 cell count is slowly on the downward slope, and has now plunged to below the critical 200 mark. That clinically means that he is no longer HIV positive, but now has AIDS.
COLLEN: Last year November, it was 300+’¦ This year, round about January, it was 255. Now it’s 198.
KHOPOTSO: Collen has been doing his CD4 count tests at the Helen Joseph Hospital in Johannesburg, and was due for antiretroviral therapy. But he was discouraged from it and offered multi-vitamin supplements as an option.
COLLEN: Actually, yes’¦ the first week of August I was going to be starting my ARVs, but Tessa came up with supplements and nutrition. And I thought it’s better if I can try them out and see how they will do because, quite honestly, I look very well, and I look very healthy, and I feel healthy.
KHOPOTSO: Collen admits that the constant free fall of his CD4 cell count is worrisome. But he still won’t go on to antiretrovirals.
COLLEN: I’ve got a friend of mine that has been on that. There’s a couple of side-effects that happened to him’¦ He’s recently had a fit. So, I told myself ‘if that can happen and he’s on the medication, what will happen to me?’ Then, I said, ‘no, I won’t go on it’.
KHOPOTSO: Coupled with what he has heard from Tessa, Collen is, quite understandably, scared. But perhaps he should be told that only 10 percent of people develop serious side-effects from antiretroviral medication and most side-effects can be managed effectively. Without the true facts and with plenty of confusing messages, including from policy-makers, many HIV infected South Africans are scared and confused about what to do about their infection. Government’s HIV and AIDS Care and Treatment Plan has antiretroviral drugs as its primary intervention, in combination with vitamin supplements and certain traditional medicines. South Africans living with HIV should be offered all these and be given proper information about ARVs by trained health workers.
E-mail Khopotso Bodibe
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Taking advantage of mixed messages
Living with AIDS # 229
by Khopotso Bodibe, Health-e News
September 7, 2005
Related
Tenofovir shortages continue
The continued stock out of the antiretroviral tenofovir and the failure to advise health workers on how to deal with it is a looming disaster, HIV Clinicians and activists are warning.
Mofolo Hospice ‘ juggling life and death
‘Miracles’ have been taking place at Mofolo Hospice with the arrival of anti-retrovirals as patients admitted on the brink of death leave the in-patient unit on their own two feet.
Acute burden of active TB in HIV+ kids
Scientists are trying to protect children born to HIV positive mothers from getting TB, the most common infection suffered by people with HIV.